PATENT CLAIM ANALYSIS

Application Number: 16054899
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "210210"]

Abstract:
A compound having the structure set forth in Formula (I) and Formula (II): wherein the substituents Y, Z, A, B, R 1 , R 2 , R 3 , R 4  and R 5  are as defined herein. Provided herein are inhibitors of poly(ADP-ribose)polymerase activity. Also described herein are pharmaceutical compositions that include at least one compound described herein and the use of a compound or pharmaceutical composition described herein to treat diseases, disorders and conditions associated with a PTEN deficiency that are ameliorated by the inhibition of PARP activity.

Claim (Index 26):
The method of  claim 25 , wherein said administration is in combination with ionizing radiation, one or more chemotherapeutic agents, or a combination thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.64615
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13020619', '13972166', '13787496', '13077785', '12510096']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8240505474326874
- 35 USC 102 Novelty (BERT): 0.5557620193318022
- Combined Prediction Score: 0.7972216946225988
- Mean Citation Score: 355.604602
- Max Citation Score: 457.08914
- Similarity Product: 335.6636396421778

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test